Log in
Enquire now
Genprex

Genprex

Genprex is an immunogene Therapy founded in 2010.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
B2X
B2B
B2B
0
Blog
genprex.com/news/cate...log-posts/
Board of Directors
Rodney Varner
Rodney Varner
0
‌
William Wilson, Jr.
0
James Rothman
James Rothman
0
‌
Brent M. Longnecker
0
CAGE Code
88R70
0
CEO
Rodney Varner
Rodney Varner
0
CFO
‌
Ryan M. Confer
0
CIK Number
1,595,248
0
Legal Name
Genprex, Inc.
Company Operating Status
Active
Contact Page URL
genprex.com/contact/
Country
United States
United States
0
Crunchbase URL
crunchbase.com/organiz.../genprex
DUNS Number
116914484
0
Facebook URL
@genprexinc
Founded Date
2010
0
Full Address
3300 Bee Cave Road, Suite 650-227 Austin, TX 78746, USA
0
Headquarters
Austin, Texas
Austin, Texas
0
Industry
Healthcare
Healthcare
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Technology
Technology
Cancer
Cancer
Oncology
Oncology
Consumer biotechnology
Consumer biotechnology
Biology
Biology
Biotechnology
Biotechnology
Internal medicine
Internal medicine
•••
IRS Number
900,772,347
0
Latest Funding Round Date
November 2019
Latest Funding Round Amount (USD)
1,457,274
LinkedIn URL
@company/genprex-inc-
Location
Austin, Texas
Austin, Texas
0
NAICS Code
325,412
0
Number of Employees (Ranges)
11 – 50
Pitchbook URL
pitchbook.com/profiles.../88056-37
Place of Incorporation
Texas
Texas
0
SIC Code
2,834
0
Exchange
Nasdaq
Nasdaq
0
Stock Symbol
GNPX
0
Ticker Symbol
GNPX
Total Funding Amount (USD)
21,457,274
Twitter URL
@genprex
Official Website
genprex.com

Find more companies like Genprex

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.